新型冠狀病毒

Coronavirus outbreak causes supply problem for India’s drugmakers

The price of many pharmaceutical ingredients has spiked for Indian drugmakers following panic buying and Chinese raw material shortages caused by the coronavirus lockdown.

The price of azithromycin and other mainstream antibiotics has risen 50 per cent since the outbreak became public in January, said Rahul Soni, chief executive of Overseas Healthcare, a drug manufacturer based in the northern Indian city of Jalandhar.

“When this virus wasn’t there, the rate we got from [importers] was Rs7,300 ($102) per kg. Today it is Rs10,500 per kg. Prices are extremely high. It’s a big problem,” said Mr Soni.

您已閱讀19%(602字),剩餘81%(2622字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×